Panobinostat PK/PD profile in combination with bortezomib and dexamethasone in patients with relapsed and relapsed/refractory multiple myeloma
Crossref DOI link: https://doi.org/10.1007/s00228-015-1967-z
Published Online: 2015-10-22
Published Print: 2016-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mu, Song
Kuroda, Yoshiaki
Shibayama, Hirohiko
Hino, Masayuki
Tajima, Takeshi
Corrado, Claudia
Lin, Rong
Waldron, Edward
Binlich, Florence
Suzuki, Kenshi
Funding for this research was provided by:
National Cancer Institute (US)
License valid from 2015-10-22